La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Humana Gestione

Gestione criteri di controllo 2/4

Humana's Il CEO è Jim Rechtin, nominato in Jan2024, ha un mandato di meno di un anno. possiede direttamente 0% delle azioni della società, per un valore di $ 4.22K. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 2 anni e 3.9 anni.

Informazioni chiave

Jim Rechtin

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEO	n/a
Mandato del CEO	less than a year
Proprietà del CEO	0.00001%
Durata media del management	2.1yrs
Durata media del Consiglio di amministrazione	4yrs

Aggiornamenti recenti sulla gestione

Recent updates

AMMINISTRATORE DELEGATO

Jim Rechtin (53 yo)

less than a year

Mandato

Mr. James A. Rechtin, also known as Jim, MBA, served as COO of Humana Inc. since January 08, 2024 until July 01, 2024 and serves as its President since January 08, 2024 and also serves as its Chief Executi...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Susan Diamond	Chief Financial Officer	3.3yrs	US$4.73m	0.0072% $ 2.8m
Joseph Ventura	Chief Legal Officer	5.6yrs	US$3.10m	0.0060% $ 2.3m
Bruce Broussard	Strategic Advisor	less than a year	US$16.33m	0.073% $ 28.2m
George Renaudin	President of Medicare & Medicaid	1.6yrs	US$3.11m	0.0032% $ 1.2m
Sanjay Shetty	President of CenterWell	1.5yrs	US$4.58m	0.00014% $ 53.9k
James Rechtin	President	less than a year	Nessun dato	0.000010% $ 3.8k
John-Paul Felter	Senior VP	2.1yrs	Nessun dato	0.00031% $ 119.3k
Eric Tagliere	Senior VP & CTO	less than a year	Nessun dato	Nessun dato
Samir Deshpande	Chief Information Officer	3.7yrs	Nessun dato	0.010% $ 4.0m
Timothy Huval	Chief Administrative Officer	5.2yrs	US$3.73m	0.0061% $ 2.4m
Lisa Stoner	Vice President of Investor Relations	no data	Nessun dato	Nessun dato
Vishal Agrawal	Chief Strategy & Corporate Development Officer	5.8yrs	Nessun dato	0.0090% $ 3.5m

2.1yrs

Durata media

51.5yo

Età media

Gestione esperta: Il team dirigenziale di HUM è considerato esperto (durata media dell'incarico 2 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
James Rechtin	President	less than a year	Nessun dato	0.000010% $ 3.8k
Kurt Hilzinger	Independent Chairman of the Board	21.2yrs	US$601.30k	0.016% $ 6.2m
Karen Katz	Independent Director	5yrs	US$346.55k	0.00049% $ 188.5k
Frank D'Amelio	Independent Director	21yrs	US$363.55k	0.017% $ 6.6m
Jorge Mesquita	Independent Director	3.6yrs	US$351.59k	0.0018% $ 684.9k
Brad Smith	Independent Director	2yrs	US$311.07k	0.00032% $ 123.1k
Wayne Frederick	Independent Director	4.6yrs	US$364.87k	0.00037% $ 142.4k
David Feinberg	Independent Director	2.5yrs	US$321.52k	0.00037% $ 142.4k
Marcy Klevorn	Independent Director	3.6yrs	US$351.94k	0.00036% $ 138.5k
John Garratt	Independent Director	4.6yrs	US$326.03k	0.0010% $ 400.2k
RaQuel Bono	Independent Director	4yrs	US$345.03k	0.00033% $ 127.0k

4.0yrs

Durata media

62yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di HUM sono considerati esperti (durata media dell'incarico 3.9 anni).

Humana Gestione

Gestione criteri di controllo 2/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Humana Inc., Annual General Meeting, Apr 18, 2024

Humana Inc., Annual General Meeting, Apr 18, 2024

President exercised options and sold US$1.3m worth of stock

Humana Inc. Announces Management Changes

Chief Financial Officer recently sold US$415k worth of stock

Chief Financial Officer notifies of intention to sell stock

Recent updates

Upcoming dividend of US$0.89 per share

Humana's Falling Share Price Gives Investors An Opportunity

Humana (NYSE:HUM) Seems To Use Debt Quite Sensibly

Humana (NYSE:HUM) Is Paying Out A Dividend Of $0.885

Second quarter dividend of US$0.89 announced

Humana Settles for $90 Million Groundbreaking False Claims Act Case Alleging Medicare Part D Prescription Drug Program Fraud

Humana Inc. Declares Cash Dividend, Payable on October 25, 2024

Second quarter 2024 earnings: EPS in line with analyst expectations despite revenue beat

Humana Inc. Revises Earnings Guidance for the Year Ending December 31, 2024

Humana: Outlook Improving Ahead Of Q2 Earnings, 'Buy' Thesis Intact

Investors Interested In Humana Inc.'s (NYSE:HUM) Earnings

Humana Inc. to Report Q2, 2024 Results on Jul 31, 2024

Humana: Medicare Advantage Will Never Be As Profitable As It Was

Humana (NYSE:HUM) Is Due To Pay A Dividend Of $0.885

Humana (NYSE:HUM) Will Pay A Dividend Of $0.885

Gainey Mckenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Humana, Inc

Humana Is Set Up For Long-Term Success

Humana (NYSE:HUM) Has Affirmed Its Dividend Of $0.885

First quarter 2024 earnings: EPS in line with analyst expectations despite revenue beat

Humana Inc. Revises Earnings Guidance for the Year Ending December 31, 2024

Humana (NYSE:HUM) Is Paying Out A Dividend Of $0.885

Dividend of US$0.89 announced

Here's Why Humana (NYSE:HUM) Can Manage Its Debt Responsibly

Humana Inc. Declares Cash Dividend, Payable on July 26, 2024

Humana Inc. to Report Q1, 2024 Results on Apr 24, 2024

Humana: Where To Buy This

Humana: This Year's Drop Might Have Created A Buying Opportunity

Humana Inc., Annual General Meeting, Apr 18, 2024

Humana Inc., Annual General Meeting, Apr 18, 2024

Humana Inc. Declares Cash Dividend, Payable on April 26, 2024

Humana: A Golden Buying Opportunity As Fears Potentially Peaked

Humana Inc. Provides Earnings Guidance for 2024

Humana: The $300 Level Could Get Taken Out In The Near Future

Humana Announces Limited Layoffs

Humana: My Oh My, Another Strong Buy

Humana: Buy This Powerful Dividend Growth Stock In The New Year

Upcoming dividend of US$0.89 per share at 0.8% yield

President exercised options and sold US$1.3m worth of stock

Does Humana (NYSE:HUM) Have A Healthy Balance Sheet?

Humana: Failed Merger And Other Reasons To Buy

Cigna Reportedly Ends Humana Merger Talks

Cigna, Humana Reportedly in Talks for Merger

Humana Inc. Declares Cash Dividend, Payable on January 26, 2024

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Humana Inc. Announces Management Changes

Humana Inc. to Report Q3, 2023 Results on Nov 01, 2023

Humana: Upgrade To Buy

Humana Inc. (NYSE:HUM) agreed to acquire Senior-focused primary care centers in Texas and Nevada of Cano Health, LLC for $66.7 million.

Humana: Buy This Amazing Wealth Compounder Now, You'll Be Glad You Did

Upcoming dividend of US$0.89 per share at 0.7% yield

Centerwell Senior Primary Care Introduces In-Home Primary Care

We Think Humana (NYSE:HUM) Can Manage Its Debt With Ease

Humana Inc. Declares Cash Dividend, Payable on October 27, 2023

Humana Inc. Revises Earnings Guidance for the Year Ending December 31, 2023

Humana: Mr. Market Got This One Right

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Humana: Recent Selloff Might Present A Buying Opportunity

Humana Inc. to Report Q2, 2023 Results on Aug 02, 2023

Humana: Rising Medical Costs Should Be Temporary

Upcoming dividend of US$0.89 per share at 0.8% yield

Humana: Margin Expansion Supported By Growing Memberships

Humana (NYSE:HUM) Seems To Use Debt Rather Sparingly

Chief Financial Officer recently sold US$415k worth of stock

Chief Financial Officer notifies of intention to sell stock

First quarter 2023 earnings: Revenues exceed analyst expectations

Humana Inc. (NYSE:HUM) Shares Could Be 49% Below Their Intrinsic Value Estimate

Upcoming dividend of US$0.89 per share at 0.7% yield

High number of new directors

President notifies of intention to sell stock